H.C. Wainwright Starts Regenxbio Inc. (RGNX) at Buy; 'Advancing Gene Therapies in Ophthalmology and Rare Diseases'
Tweet Send to a Friend
(Updated - March 12, 2024 6:51 AM EDT)
H.C. Wainwright analyst Yi Chen initiates coverage on Regenxbio Inc. (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
H.C. Wainwright analyst Yi Chen initiates coverage on Regenxbio Inc. (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
